Tianjin Ringpu Bio Tech - Asset Resilience Ratio

Latest as of March 2026: 14.27%

Tianjin Ringpu Bio Tech (300119) has an Asset Resilience Ratio of 14.27% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Tianjin Ringpu Bio Tech to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.11 Billion

≈ $162.89 Million USD Cash + Short-term Investments

Total Assets

CN¥7.80 Billion

≈ $1.14 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Tianjin Ringpu Bio Tech's Asset Resilience Ratio has changed over time. See Tianjin Ringpu Bio Tech (300119) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Ringpu Bio Tech's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tianjin Ringpu Bio Tech market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.11 Billion	14.27%
Total Liquid Assets	CN¥1.11 Billion	14.27%

Asset Resilience Insights

Moderate Liquidity: Tianjin Ringpu Bio Tech has 14.27% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Tianjin Ringpu Bio Tech Industry Peers by Asset Resilience Ratio

Compare Tianjin Ringpu Bio Tech's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Tianjin Ringpu Bio Tech (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Tianjin Ringpu Bio Tech.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	13.62%	CN¥1.04 Billion ≈ $152.58 Million	CN¥7.66 Billion ≈ $1.12 Billion	-4.60pp
2024-12-31	18.22%	CN¥1.45 Billion ≈ $212.36 Million	CN¥7.97 Billion ≈ $1.17 Billion	-1.24pp
2023-12-31	19.46%	CN¥1.28 Billion ≈ $187.80 Million	CN¥6.60 Billion ≈ $965.19 Million	-5.12pp
2022-12-31	24.58%	CN¥1.50 Billion ≈ $219.62 Million	CN¥6.11 Billion ≈ $893.54 Million	+14.42pp
2021-12-31	10.15%	CN¥577.88 Million ≈ $84.56 Million	CN¥5.69 Billion ≈ $832.74 Million	-0.10pp
2020-12-31	10.25%	CN¥399.83 Million ≈ $58.51 Million	CN¥3.90 Billion ≈ $570.58 Million	-0.56pp
2019-12-31	10.81%	CN¥385.29 Million ≈ $56.38 Million	CN¥3.56 Billion ≈ $521.42 Million	+1.57pp
2018-12-31	9.25%	CN¥277.21 Million ≈ $40.56 Million	CN¥3.00 Billion ≈ $438.77 Million	+2.14pp
2017-12-31	7.11%	CN¥207.80 Million ≈ $30.41 Million	CN¥2.92 Billion ≈ $427.90 Million	-2.54pp
2016-12-31	9.64%	CN¥263.60 Million ≈ $38.57 Million	CN¥2.73 Billion ≈ $399.95 Million	+6.69pp
2015-12-31	2.95%	CN¥69.30 Million ≈ $10.14 Million	CN¥2.35 Billion ≈ $343.67 Million	--

pp = percentage points

About Tianjin Ringpu Bio Tech

SHE:300119 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

CN¥7.06 Billion CNY

Market Cap Rank

#8931 Global

#2248 in China

Share Price

CN¥15.20

Change (1 day)

-0.65%

52-Week Range

CN¥15.08 - CN¥23.48

All Time High

CN¥39.94